Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


Articles published in Endocrinology

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    April 2019
  1. TAKAYAMA KI, Inoue S
    Response to Letter to the Editor: "Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer".
    Endocrinology. 2019 Apr 3. pii: 5425392. doi: 10.1210/en.2019-00207.
    PubMed     Text format    


    March 2019
  2. YANG C, Shen X, Ma R, Liu X, et al
    Letter to the Editor: "Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer".
    Endocrinology. 2019 Mar 28. pii: 5421009. doi: 10.1210/en.2019-00138.
    PubMed     Text format     Abstract available


    January 2019
  3. TAKAYAMA KI, Suzuki Y, Yamamoto S, Obinata D, et al
    Integrative genomic analysis of OCT1 reveals coordinated regulation of androgen receptor in advanced prostate cancer.
    Endocrinology. 2019 Jan 11. pii: 5286515. doi: 10.1210/en.2018-00923.
    PubMed     Text format     Abstract available


    September 2018
  4. GHINEA N
    Vascular Endothelial FSH Receptor, a Target of Interest for Cancer Therapy.
    Endocrinology. 2018;159:3268-3274.
    PubMed     Text format     Abstract available


    May 2018
  5. HETTEL D, Zhang A, Alyamani M, Berk M, et al
    AR Signaling in Prostate Cancer Regulates a Feed-forward Mechanism of Androgen Synthesis by Way of HSD3B1 Upregulation.
    Endocrinology. 2018 May 29. pii: 5005852. doi: 10.1210/en.2018-00283.
    PubMed     Text format     Abstract available


    February 2018
  6. KAWANAMI T, Tanaka T, Hamaguchi Y, Nomiyama T, et al
    Selective androgen receptor modulator S42 suppresses prostate cancer cell proliferation.
    Endocrinology. 2018 Feb 12. pii: 4850601. doi: 10.1210/en.2018-00099.
    PubMed     Text format     Abstract available


    December 2017
  7. WANG Y, Pascal LE, Zhong M, Ai J, et al
    Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
    Endocrinology. 2017;158:4189-4205.
    PubMed     Text format     Abstract available


    October 2017
  8. MASOODI KZ, Eisermann K, Yang Z, Dar JA, et al
    Inhibition of Androgen Receptor Function and Level in Castration-Resistant Prostate Cancer Cells by 2-[(isoxazol-4-ylmethyl)thio]-1-(4-phenylpiperazin-1-yl)ethanone.
    Endocrinology. 2017;158:3152-3161.
    PubMed     Text format     Abstract available


  9. SARMENTO-CABRAL A, L-Lopez F, Luque RM
    Adipokines and Their Receptors Are Widely Expressed and Distinctly Regulated by the Metabolic Environment in the Prostate of Male Mice: Direct Role Under Normal and Tumoral Conditions.
    Endocrinology. 2017;158:3540-3552.
    PubMed     Text format     Abstract available


    April 2017
  10. RECOUVREUX MV, Wu B, Gao AC, Zonis S, et al
    Androgen receptor regulation of local growth hormone in prostate cancer cells.
    Endocrinology. 2017 Apr 21. doi: 10.1210/en.2016-1939.
    PubMed     Text format     Abstract available


    March 2017
  11. HO Y, Dehm SM
    Androgen Receptor Rearrangement and Splicing Variants in Resistance to Endocrine Therapies in Prostate Cancer.
    Endocrinology. 2017 Mar 27. doi: 10.1210/en.2017-00109.
    PubMed     Text format     Abstract available


  12. PU H, Begemann D, Kyprianou N
    Aberrant TGF-beta Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis.
    Endocrinology. 2017 Mar 16. doi: 10.1210/en.2017-00086.
    PubMed     Text format     Abstract available


    January 2017
  13. AUDET-WALSH E, Yee T, Tam IS, Giguere V, et al
    Inverse regulation of DHT synthesis enzymes 5alpha Reductase Types 1 and 2 by the androgen receptor in prostate cancer.
    Endocrinology. 2017 Jan 23. doi: 10.1210/en.2016-1926.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: